Analysis of a large cohort of primary samples did not detect significant gene rearrangements or copy-number gains in breast cancer, indicating that activation of the EVI1 locus in breast cancer follows different principles than in myeloid leukemia, possibly via miRNA regulation [1, 13]. The gene discussed is MECOM; the disease is breast cancer.